"For the first time, a PI3K pathway-targeted drug has shown it can help people with this breast cancer subtype live longer," said Levi Garraway, M.D., Ph.D., Roche's Chief Medical Officer and Head of ...

“Instead I’ll be on Letrozole + Kisqali + Zoladex as my first line of treatment,” she wrote. “This is a custom plan based on being [/] having HER2-negative, Luminal B, hormone-positive ...

Supporting your health & well-being at every stage of your breast cancer journey ...

Targeted therapies are a relatively new form of treatment for breast cancer and may be used alone or in combination with other treatments. Unlike traditional chemotherapy, which attacks any rapidly ...